Angelini Pharma acquires Catalyst at $31.50 a share for $4.1B

July 16, 2026 3:36 AM

Angelini Pharma S.p.A. has completed its acquisition of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), with each share of Catalyst common stock ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found